NSEDCP
ARNA

NJ State Employees Deferred Compensation Plan’s Arena Pharmaceuticals Inc ARNA Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,200
Closed -$669K – 507
2021
Q4 		$669K Hold
7,200
– – 0.08% 242
2021
Q3 		$429K Hold
7,200
– – 0.06% 322
2021
Q2 		$491K Hold
7,200
– – 0.07% 302
2021
Q1 		$500K Buy
+7,200
New +$554K 0.07% 302

NJ State Employees Deferred Compensation Plan's ARNA Position: Q1 2022 in Review

NJ State Employees Deferred Compensation Plan sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 7,200 shares — an estimated $669K sold.

NJ State Employees Deferred Compensation Plan first reported a position in ARNA in Q1 2021 and held it in 4 quarters. The position peaked at $669K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • NJ State Employees Deferred Compensation Plan reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 7,200 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $669K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Arena Pharmaceuticals Inc in Q1 2021 and held it in 4 quarters.
  • NJ State Employees Deferred Compensation Plan's Arena Pharmaceuticals Inc position peaked at $669K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2022, filed 2 May 2022.